Effective August 19, 2026
Source hierarchy
We prioritize authoritative regulatory records, trial registries, peer-reviewed primary research, and maintained scientific databases. News reports and social posts may identify a topic, but they do not become the sole support for a medical claim.
Claim discipline
We distinguish ingredient from product, mechanism from outcome, association from causation, and regulatory status from emerging research. Population, dose, formulation, comparator, endpoint, and duration remain attached when they materially affect interpretation.
Daily Brief standards
Briefings will link to the underlying record, distinguish what happened from what it may mean, and identify material conflicts or limitations. Sponsored placement will never determine a scientific conclusion. Any sponsorship or financial relationship will be labeled where readers encounter it.
Corrections and revisions
Material corrections should identify what changed and why. Source updates, corrections, retractions, and new conflicting evidence may trigger a revised profile or briefing. Versioned evidence records are preserved when available.
Conflicts and independence
Peplexicon does not currently sell peptides or accept paid placement in evidence rankings. If commercial relationships are introduced, they will be disclosed and separated from editorial assessment.
Read the method
For the technical publication model, assurance controls, and coverage boundaries, read the evidence methodology.